Pakistan’s first biopharma plant introduces breakthrough diabetes drug Zeptide
- Tirzepatide launched as pre-filled syringe, developed using IPO proceeds, BF Biosciences says
- Pakistan faces one of the world’s highest diabetes burdens, affecting over 33 million adults